• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
drug prices biologics drug costs IRA money cash payment co-pay
Special Reports

Top 20 pharma companies by 2025 revenue

2025 was a solid year overall in the biopharma industry as 16 of the world's top 20 companies achieved growth, led by Eli Lilly with a staggering 45% increase in revenue.
Kevin Dunleavy Apr 20, 2026 3:00am
3D render of digital cloud and circuit board

Deerfield trots into sales software with CRM-enhancing tool

Apr 23, 2026 5:22am
Brain Cancerjpg

Why Molecular Testing Is Key to Brain Cancer Diagnosis

Brought to you by Jazz Pharmaceuticals
AbbVie

AbbVie to establish NC production base with $1.4B investment

Apr 22, 2026 12:47pm
Two dosing pens of semaglutide
Favicon Fierce Healthcare

CMS delays Part D GLP-1 model amid skepticism from insurers

Apr 22, 2026 12:00pm
MA

Amneal ponies up $1.1B for biosimilars specialist Kashiv

Apr 22, 2026 11:32am
More News

Union strike looms at Samsung Bio amid massive revenue growth

Apr 22, 2026 11:28am

Regulatory tracker: Sanofi's subQ Sarclisa delayed at FDA

Apr 22, 2026 11:05am

Merck goes with Google for AI push, strikes $1B enterprise deal

Apr 22, 2026 10:12am

FDA signs off on Merck's HIV combo pill Idvynso

Apr 21, 2026 3:26pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings